THE GLOBAL LINEUP AT BIOCHINA 2027.
2026.11.2
International momentum is accelerating. Delegation groups and industry leaders from 15 countries have already confirmed their participation for Suzhou, securing early booth space and partnering passes.
Key International Players On Board:
· United States: Veristat, Zealand Pharma, Norwest
· Japan: Maruho, CMIC, Satoru Suzuki Pharma, NANO MRNA
· South Korea: KPBM Association, Incheon Technopark, Shaperon
· Switzerland & Sweden: Novartis, Embassy of Sweden in China
· Australia & Pakistan: Scindea, AUScelerate, SMCT, Matrics Research
· Global Hubs: Top representatives from Portugal, Russia, Canada, Italy, Belgium, Brazil, and Bangladesh
With cross-border BD and face-to-face dealmaking at an all-time high, now is the time to position your brand alongside global industry leaders.
Booth early bird and secure your rate by Nov 27, 2026. →https://u.morebio.cn/viQv63DM